Dogwood Therapeutics, Inc. Earnings Per Share (Basic)
Dogwood Therapeutics, Inc. (DWTX) reported Earnings Per Share (Basic) of -$0.34 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- Dogwood Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.34.
- Dogwood Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.15.
- Dogwood Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.26.
- Dogwood Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$8.20.
- Dogwood Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$7.13.
- Dogwood Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$12.52.
- Dogwood Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$7.05.
- Dogwood Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$1.11.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.34 10-Q · filed 2026-08-14 | -$0.49 10-Q · filed 2026-08-14 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.71 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | -$0.15 10-Q · filed 2026-05-15 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$1.47 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$2.18 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-03-18 | -$2.36 derived: net income ÷ weighted average shares · filed 2026-03-18 | -$3.79 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$7.13 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | -$8.20 10-Q · filed 2025-11-07 | -$10.21 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$18.02 10-Q · filed 2025-11-07 | -$24.28 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$1.99 10-Q · filed 2026-08-14 | -$9.51 10-Q · filed 2026-08-14 | -$15.58 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$18.36 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-03-31 | -$8.45 10-Q · filed 2026-05-15 | -$14.83 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$17.63 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$19.88 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||||
| 2024-12-31 | -$6.28 derived: net income ÷ weighted average shares · filed 2026-03-18 | -$8.69 derived: net income ÷ weighted average shares · filed 2026-03-18 | -$10.40 derived: net income ÷ weighted average shares · filed 2026-03-18 | -$12.52 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | -$2.05 10-Q · filed 2025-11-07 | -$3.29 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$4.95 10-Q · filed 2025-11-07 | |||||
| 2024-06-30 | -$1.15 10-Q · filed 2025-08-13 | -$0.05 10-Q · filed 2024-08-09 | -$2.78 10-Q · filed 2025-08-13 | -$0.11 10-Q · filed 2024-08-09 | ||||
| 2024-03-31 | -$1.68 10-Q · filed 2025-05-09 | -$0.07 10-Q · filed 2024-05-10 | ||||||
| 2023-12-31 | -$7.05 10-K · filed 2025-03-31 | -$0.28 10-K · filed 2024-03-01 | ||||||
| 2023-09-30 | -$1.62 10-Q · filed 2024-11-08 | -$0.06 10-Q · filed 2023-11-13 | -$5.63 10-Q · filed 2024-11-08 | -$0.23 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | -$0.08 10-Q · filed 2024-08-09 | -$0.16 10-Q · filed 2024-08-09 | ||||||
| 2023-03-31 | -$0.08 10-Q · filed 2024-05-10 | |||||||
| 2022-12-31 | -$1.11 10-K/A · filed 2024-03-08 | |||||||
| 2022-09-30 | -$0.28 10-Q · filed 2023-11-13 | -$1.18 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | -$0.44 10-Q · filed 2023-08-11 | -$0.92 10-Q · filed 2023-08-11 | ||||||
| 2022-03-31 | -$0.48 10-Q · filed 2023-05-12 | |||||||
| 2021-12-31 | -$1.92 10-K · filed 2023-03-14 | |||||||
| 2021-09-30 | -$0.49 10-Q · filed 2022-11-14 | -$1.37 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.51 10-Q · filed 2022-08-12 | -$0.88 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | -$0.37 10-Q · filed 2022-05-13 | |||||||
| 2020-12-31 | -$2.10 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |